Dark Matter Longevity Fund

Meet the Team

Behind the Science

Leadership Investment professionals with operational backgrounds in gene therapy, consumer products, and venture infrastructure.

Mark Moline

Mark Moline

Managing Director

100+ company track record in SaaS, blockchain, gaming, medtech, and biotech. Co-founded Olivon Advisors. Founded Seraph syndicate: $70M+ deployed across 50+ companies in 16 countries.

LinkedIn

Skinner Layne

Skinner Layne

Managing Director

Founded Exosphere: deep tech education, 2,500+ students. 16 years abroad. Operational experience in genomics and gene therapy. Built AI-native infrastructure powering fund operations.

LinkedIn

Dark Matter Longevity Fund

Meet the Team

Behind the Science

Leadership Investment professionals with operational backgrounds in gene therapy, consumer products, and venture infrastructure.

Woman

Mark Moline

Managing Director

100+ company track record in SaaS, blockchain, gaming, medtech, and biotech. Co-founded Olivon Advisors. Founded Seraph syndicate: $70M+ deployed across 50+ companies in 16 countries.

LinkedIn

Skinner Layne

Skinner Layne

Managing Director

Founded Exosphere: deep tech education, 2,500+ students. 16 years abroad. Operational experience in genomics and gene therapy. Built AI-native infrastructure powering fund operations.

LinkedIn

Dark Matter Longevity Fund

Meet the Team

Behind the Science

Leadership Investment professionals with operational backgrounds in gene therapy, consumer products, and venture infrastructure.

Mark Moline

LinkedIn

Mark Moline

Managing Director

100+ company track record in SaaS, blockchain, gaming, medtech, and biotech. Co-founded Olivon Advisors. Founded Seraph syndicate: $70M+ deployed across 50+ companies in 16 countries.

Skinner Layne

LinkedIn

Skinner Layne

Managing Director

Founded Exosphere: deep tech education, 2,500+ students. 16 years abroad. Operational experience in genomics and gene therapy. Built AI-native infrastructure powering fund operations.